Meningitis News and Research

Latest Meningitis News and Research

Non-therapeutic antibiotic usage in food animals creates resistance genes, promotes antibiotic resistance

In a review study, researchers from Tufts University School of Medicine zero in on the controversial, non-therapeutic use of antibiotics in food animals and fish farming as a cause of antibiotic resistance.

16 Nov 2011

Researchers to begin drug development projects for rare and neglected diseases

Researchers will begin drug development projects for rare and neglected diseases that include potential treatments for a musculoskeletal disorder, a cognitive dysfunction disorder, a virus that affects the central nervous system of newborns, a parasitic worm infection, a form of muscular dystrophy and a rare lung disease.

16 Nov 2011

Pneumococcal vaccine Prevnar13 effective in seniors

Pneumococcal disease kills millions worldwide and the largest affected groups are children and the elderly. Federal health scientists now assure that the popular pneumococcal vaccine Prevnar is at least as effective as a rival vaccine at protecting adults from the sometimes-deadly infection.

15 Nov 2011

Scientists determine atomic structure of Lassa fever viral protein

Scientists at The Scripps Research Institute have determined the atomic structure of a protein that the Lassa fever virus uses to make copies of itself within infected cells.

15 Nov 2011

Sinovac third quarter sales increase 60.8% to $15.4 million

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today its unaudited third quarter financial results for the period ended September 30, 2011.

14 Nov 2011

IVI receives WHO prequalification for new oral cholera vaccine

Shanchol-, a new oral cholera vaccine developed through the International Vaccine Institute (IVI), an international organization established by the United Nations and based in Seoul, recently received prequalification from the World Health Organization.

13 Nov 2011

Vaccination dramatically reduces incidence of Hib disease in young children

Vaccination against Haemophilus influenzae type b, or Hib, once the most common cause of bacterial meningitis in children, has dramatically reduced the incidence of Hib disease in young children over the past 20 years, according to a study published in Clinical Infectious Diseases and available online.

11 Nov 2011

Bacteria rapidly exchange genetic information related to human disease and antibiotic resistance

Much as people can exchange information instantaneously in the digital age, bacteria associated with humans and their livestock appear to freely and rapidly exchange genetic material related to human disease and antibiotic resistance through a mechanism called horizontal gene transfer (HGT).

2 Nov 2011

Some experts question early release of RTS,S malaria vaccine trial data

Nature News reports on last week's announcement of preliminary results from a large clinical trial testing the efficacy of GlaxoSmithKline's (GSK) RTS,S malaria vaccine, writing that while media coverage of the announcement touted it as a "big breakthrough in the long campaign to create a malaria vaccine," "several leading vaccine researchers, who are critical of the unusual decision to publish partial trial data, argue that the results raise questions about whether the RTS,S/AS01 candidate vaccine can actually win approval."

29 Oct 2011

New vaccine to eradicate meningitis

Outbreaks of meningitis can quickly reach epidemic proportions across a number of African countries, afflicting tens of thousands of people. Now a new vaccine appears capable of completely eradicating the disease.

28 Oct 2011

EC approves Pfizer's pneumococcal conjugate vaccine, Prevenar 13

Pfizer Inc. announced today that the European Commission has approved the Company's pneumococcal conjugate vaccine, Prevenar 13 (pneumococcal polysaccharide conjugate vaccine, for active immunization for the prevention of vaccine-type invasive disease caused by Streptococcus pneumoniae in adults aged 50 years and older.

27 Oct 2011

Scientists, WHO warn of public health implications of proposed mercury ban due to its use in vaccines

"Scientists are warning officials negotiating a global treaty on mercury that banning the deadly chemical completely would be dangerous for public health because of the chemical's use in vaccines," the Associated Press reports.

24 Oct 2011

Pfizer's Prevnar 13: Additional data from adult clinical studies presented at 49th IDSA

Pfizer Inc. announced today that additional data from several clinical studies of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine) conducted in adults 50 years and older will be presented during the 49th Annual Meeting of the Infectious Diseases Society of America, which is being held Oct. 20-23, 2011, in Boston, Mass.

22 Oct 2011

Treating TB, HIV co-infections early, aggressively can save lives, multiple studies show

"Treating tuberculosis (TB) and HIV infections at the same time can be a challenge for patients and their doctors, but attacking both diseases early and aggressively isn't harmful and could save the lives of those who are sickest," according to a global study led by researchers from the University of California, San Francisco (UCSF) and published Wednesday in the New England Journal of Medicine (NEJM), the San Francisco Chronicle reports.

21 Oct 2011

RTS,S vaccine reduces risk of severe malaria in African children

First results from a large-scale Phase III trial of RTS,S, published online today in the New England Journal of Medicine (NEJM), show the malaria vaccine candidate to provide young African children with significant protection against clinical and severe malaria with an acceptable safety and tolerability profile.

19 Oct 2011

First results from phase 3 malaria vaccine candidate trial

18 Oct 2011

VEC and AMA release updated information guide, 'Vaccines and Teens'

This week at the annual meeting of the American Academy of Pediatrics, the Vaccine Education Center at The Children's Hospital of Philadelphia (VEC) and the American Medical Association released an updated information guide called Vaccines and Teens for parents and physicians, detailing the most current recommendations and information about critical immunizations for older children.

18 Oct 2011

Specific MIF gene variant plays a crucial role against bacterial infections

Why are some people prone to severe infections, while others handle them with less difficulty? A new research report appearing online in the FASEB Journal (http://www.fasebj.org) attempts to answer this question by shedding light on the genetic differences that influence our ability to fight off bacterial infections.

13 Oct 2011

Belfast Health, Social Care Trust license new meningitis test to HiberGene

Belfast Health and Social Care Trust has licensed its novel rapid meningitis diagnostic test to HiberGene Diagnostics Ltd, an Irish start-up client company of NovaUCD, the Innovation and Technology Transfer Centre at University College Dublin.

7 Oct 2011

Pfizer releases Phase III study results comparing VFEND-ERAXIS combination to VFEND for IA

Pfizer Inc. today reported the top-line results of an international Phase III clinical trial which compared the combination of VFEND (voriconazole) and ERAXISTM (anidulafungin) to VFEND monotherapy for primary therapy of invasive aspergillosis, a life-threatening invasive fungal infection that can develop as a complication in patients with compromised immune systems.

1 Oct 2011

Meningitis News and Research

Latest Meningitis News and Research

Non-therapeutic antibiotic usage in food animals creates resistance genes, promotes antibiotic resistance

Researchers to begin drug development projects for rare and neglected diseases

Pneumococcal vaccine Prevnar13 effective in seniors

Scientists determine atomic structure of Lassa fever viral protein

Sinovac third quarter sales increase 60.8% to $15.4 million

IVI receives WHO prequalification for new oral cholera vaccine

Vaccination dramatically reduces incidence of Hib disease in young children

Bacteria rapidly exchange genetic information related to human disease and antibiotic resistance

Some experts question early release of RTS,S malaria vaccine trial data

New vaccine to eradicate meningitis

EC approves Pfizer's pneumococcal conjugate vaccine, Prevenar 13

Scientists, WHO warn of public health implications of proposed mercury ban due to its use in vaccines

Pfizer's Prevnar 13: Additional data from adult clinical studies presented at 49th IDSA

Treating TB, HIV co-infections early, aggressively can save lives, multiple studies show

RTS,S vaccine reduces risk of severe malaria in African children

First results from phase 3 malaria vaccine candidate trial

VEC and AMA release updated information guide, 'Vaccines and Teens'

Specific MIF gene variant plays a crucial role against bacterial infections

Belfast Health, Social Care Trust license new meningitis test to HiberGene

Pfizer releases Phase III study results comparing VFEND-ERAXIS combination to VFEND for IA

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Meningitis News and Research

Latest Meningitis News and Research

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in